On ECHEMI
Home > Drugs > Shanxi Zhendong Pharmaceutical Co., Ltd.
Shanxi Zhendong Pharmaceutical Co., Ltd.
  • Founded in:

    1995-11-15
  • Country:

    China China
  • Address:

    Zhendong Science and Technology Park, Guangming South Road, Shangdang District, Changzhi City, Shanxi Province
  • Tax NO.:

    91140400729655415C
  • Registered Funds:

    1,005,319,756 yuan
  • Website:

  • Email:

Related Drugs
Paclitaxel Injection
5β,20-epoxy-1,2α,4,7β,10β,13α-hexahydroxytaxane-11-ene-9-one-4,10-diacetate-2-benzoate-13-[(2'R,3'S)-N-benzoyl-3-phenylisoserine ester
Name Description Content CAS NO. Registered Holders
Paclitaxel

This product is a new type of anti-microtubule drug. It promotes tubulin polymerization, inhibits depolymerization, maintains tubulin stability, and inhibits cell mitosis. In vitro experiments have shown that paclitaxel has a significant radiosensitization effect, which may be to stop cells in the G2 and M phases that are sensitive to radiotherapy. Paclitaxel is a mitotic inhibitor or spindle poison. It has a different mechanism of action from the commonly used chemotherapy drugs. It induces and promotes the assembly of microtubules. Paclitaxel has the effect of polymerizing and stabilizing microtubules, causing rapidly dividing tumor cells to be firmly fixed in the mitotic stage, blocking the replication of cancer cells and causing them to die.

More

This product is a new type of anti-microtubule drug. It promotes tubulin polymerization, inhibits depolymerization, maintains tubulin stability, and inhibits cell mitosis. In vitro experiments have shown that paclitaxel has a significant radiosensitization effect, which may be to stop cells in the G2 and M phases that are sensitive to radiotherapy. Paclitaxel is a mitotic inhibitor or spindle poison. It has a different mechanism of action from the commonly used chemotherapy drugs. It induces and promotes the assembly of microtubules. Paclitaxel has the effect of polymerizing and stabilizing microtubules, causing rapidly dividing tumor cells to be firmly fixed in the mitotic stage, blocking the replication of cancer cells and causing them to die.

33069-62-4 72
Matrine Injection
The main ingredient of this product is matrine.
Name Description Content CAS NO. Registered Holders
Matrine

Inhibits the replication of hepatitis B HbeAg, improves the symptoms and signs of pathological hepatitis, and has anti-cancer and anti-arrhythmic effects

More

Inhibits the replication of hepatitis B HbeAg, improves the symptoms and signs of pathological hepatitis, and has anti-cancer and anti-arrhythmic effects

519-02-8 8
Bicalutamide
Name Description Content CAS NO. Registered Holders
Bicalutamide

Extract from the above information

More

Extract from the above information

90357-06-5 36
Gastrosin
Name Description Content CAS NO. Registered Holders
Gastric Mucin

Extract from the above information

More

Extract from the above information

84082-64-4 23
Breviscapine dispersible tablets
Breviscapine
Name Description Content CAS NO. Registered Holders
BREVISCAPIN

It can reduce the brain wet weight and brain water content of rats with brain damage caused by local cerebral ischemia of the middle cerebral artery, reduce the scope of cerebral infarction, and significantly prolong the survival time of mice poisoned by sodium nitrite

More

It can reduce the brain wet weight and brain water content of rats with brain damage caused by local cerebral ischemia of the middle cerebral artery, reduce the scope of cerebral infarction, and significantly prolong the survival time of mice poisoned by sodium nitrite

116122-36-2 0
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.